What Is Oxymist - Nasal Decongestant Spray
OXYMIST is a triple action nasal decongestant spray that provides relief of a blocked nose caused by the common cold, allergic rhinitis, or sinusitis. It can also be used as adjunctive treatment in middle ear infections.³
Actives to help a blocked nose
OXYMIST 0,025: Each 1 mL of solution contains 0,25 mg oxymetazoline hydrochloride (0,025 % m/v) and 0,01 % m/v benzalkonium chloride as preservative.
OXYMIST 0,05: Each 1 mL of solution contains 0,5 mg oxymetazoline hydrochloride (0,05 % m/v) and 0,01 % m/v benzalkonium chloride as preservative.
How To Use Oxymist - Relief for a Blocked Nose
For best results keep both the head and spray bottle in an upright position.³
Remove the cap by pulling and insert the nozzle of the spray loosely into the nostril with the middle and forefinger around the bottom of the nozzle and the thumb on the base of the bottle.³
Depress the spray mechanism (as shown in the diagram) thus producing a fine mist. Sniff in to ensure an even distribution of the spray.³
Withdraw from nostril and release the spray mechanism. Repeat for your second nostril.³
Where To Buy Oxymist - Nasal Decongestant Spray
Available nationally at all leading retail and independent pharmacies.
Reg. No. 47/16.1/0792, 0793. Oxymist 0,025; 0,05. Each 1 mL of solution contains 0,25 mg oxymetazoline hydrochloride (0,025 % m/v) / 0,5 mg oxymetazoline hydrochloride (0,05 % m/v).
For full prescribing information, refer to the Professional Information approved by the medicines regulatory authority.
References: 1. Reinecke, S. & Tschaikin, M. Investigation of the effect of oxymetazoline on the duration of rhinitis. Results of a placebo-controlled double-blind study in patients with acute rhinitis. MMW Fortschr. Med 147, Suppl 3, 113-118 (2005). 2. Druce, H. M. et al. Topical nasal decongestant oxymetazoline (0,05 %) provides relief of nasal symptoms for 12 hours. Rhinology 56, 343-350 (2018). 3. Professional Information approved by the SAHPRA: Oxymist 0,025; 0,05 (Nasal Spray). 4. Thorat, S. Formulation and Product Development of Nasal Spray: An Overview. Scholars Journal of Applied Medical Sciences (SJAMS) 4, 2976–2985 (2016).
CIPLA MEDPRO (PTY) LTD. Co. Reg. No. 1995/004182/07. Building 9, Parc du Cap, Mispel Street, Bellville, 7530, RSA. Website: www.cipla.co.za Customer Care: 080 222 6662.
